STAGE II PANCREATIC CANCER AJCC V8
Clinical trials for STAGE II PANCREATIC CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II PANCREATIC CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II PANCREATIC CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a stronger blast of radiation extend life in pancreatic cancer?
Disease control Recruiting nowThis study is for people with locally advanced pancreatic cancer that cannot be removed by surgery. After 4-6 months of chemotherapy, participants will either receive higher-dose radiation or standard care (more chemo, observation, or lower-dose radiation). The goal is to see if …
Matched conditions: STAGE II PANCREATIC CANCER AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 16, 2026 23:23 UTC
-
New hope for Hard-to-Treat cancers: targeted pill shows promise in DNA-Repair defect tumors
Disease control Recruiting nowThis study is testing a daily pill called talazoparib in people with advanced solid tumors (like breast, prostate, ovarian, or pancreatic cancer) that have specific DNA repair gene mutations. The drug works by blocking a protein that helps cancer cells fix their DNA, causing them…
Matched conditions: STAGE II PANCREATIC CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New hope for pancreatic cancer: targeted pill studied in nationwide telemedicine trial
Disease control Recruiting nowThis study tests a drug called pemigatinib in people with advanced or metastatic pancreatic cancer that has certain changes in the FGFR gene. The drug aims to block these abnormal genes and stop tumor growth. About 40 adults will take the pill at home and be monitored through tel…
Matched conditions: STAGE II PANCREATIC CANCER AJCC V8
Phase: PHASE2 • Sponsor: Sameek Roychowdhury • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Light therapy boosts immune attack on tough pancreatic tumors
Disease control Recruiting nowThis study tests a new combination for people with pancreatic cancer that cannot be surgically removed. It uses a light-activated drug (verteporfin) to make tumors more responsive to immunotherapy (pembrolizumab) plus standard chemotherapy. The goal is to see if this approach shr…
Matched conditions: STAGE II PANCREATIC CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
New chemo cocktail shows promise for pancreatic cancer patients before surgery
Disease control Recruiting nowThis study tests whether giving a combination of three chemotherapy drugs (gemcitabine, cisplatin, and nab-paclitaxel) before surgery can help shrink pancreatic tumors and improve outcomes. It includes 36 adults with pancreatic cancer that is either removable or borderline remova…
Matched conditions: STAGE II PANCREATIC CANCER AJCC V8
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC
-
New drug combo aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study tests two experimental drugs, ZEN003694 and entinostat, in people with advanced solid tumors that have stopped responding to standard treatments, including pancreatic cancer. The goal is to find the safest dose and see if the combination can shrink tumors. About 49 par…
Matched conditions: STAGE II PANCREATIC CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 03, 2026 12:05 UTC
-
New drug OMO-103 tested in early pancreatic cancer trial
Knowledge-focused Recruiting nowThis early phase 1 trial is studying how the drug OMO-103 affects pancreatic cancer cells in 12 patients with advanced or metastatic pancreatic ductal adenocarcinoma. The main goal is to see if the drug changes the tumor's biology by analyzing tissue samples before and after trea…
Matched conditions: STAGE II PANCREATIC CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC
-
New study aims to unlock pancreatic cancer treatment secrets
Knowledge-focused Recruiting nowThis early-phase trial looks at how six different drugs affect pancreatic cancer tumors. Researchers will compare tumor samples taken before and after treatment to see if the drugs change the cancer's biology. The goal is to learn which drugs work best for different patients, hel…
Matched conditions: STAGE II PANCREATIC CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:12 UTC